B.S. in Life Science, Peking University;

Ph.D. in Neuroscience, University of British Columbia;

Previous Postdoctoral fellow of Neurology and ICE, Johns Hopkins University;

Dr. Fan has been elected as one of the' 30 Global Innovative talents of Chinese entrepreneurs' in 2018;

17 years of research experience in stroke and neurodegenerative disease models and mechanisms. 10 years of experience in pluripotent stem cell culture, iPSC reprogramming and neural differentiation. Since 2017, Dr. Fan has led the Hopstem team and together established the company's intellectual property layout and iPSC cell product R&D platform.

Ph.D., Albert Einstein College of Medicine

Postdoctoral Fellow, University of California, San Francisco (UCSF)

Co-founder, Chairman & Chief Scientific Officer, Neuralstem Inc.

Founder & Chief Executive Officer, ReMotor Therapeutics, Inc.

With over 32 years of experience in neuroscience and extensive expertise in the development and clinical application of neural stem cell products in both China and the United States. Previously served as Founder and CSO of Neuralstem, Inc. in the U.S., leading the team to successfully obtain FDA clearance for multiple Investigational New Drug (IND) applications for fetal neural stem cell products. Spearheaded Phase I and II clinical trials for conditions such as post-stroke hemiplegia, spinal cord injury, and ALS (amyotrophic lateral sclerosis).

Peking University Health Science Center, Master of Medicine;

Rensselaer Polytechnic Institute, USA, Ph.D.;

Albany Medical Center, USA, Postdoc;

University of Washington, USA, Instructor;

Associate professor；

Hangzhou Future Sci & Tech City Overseas High-level Talent. 2018;

As the outstanding figure in Hangzhou’s Academician Station, highlighted in Hangzhou Youth Newspaper. 2019;

Core member of Leading Innovation Team Award by Zhejiang Province. 2020;

Leader of Outstanding Team Award of Huadong Medicine. 2020;

Served as Medical director in Hangzhou Adamerck, Head of Clinical Medicine and Medical Affairs department in Huadong Medicine. In charge of the clinical development of multiple projects from IND to NDA, as well as project leaders for multiple licensed-in projects.

Master in Biomedical Engineering, Peking Union Medical College

With 30 years of experience in biopharmaceutical R&D, production, and quality control, including over 20 years of expertise in pharmaceutical quality management. Has held quality management roles at leading domestic and international pharmaceutical companies such as Baxter, WuXi Biologics, Abbott, Fresenius-Kabi, and Legend Biotech. Successfully led quality teams to zero-deficiency findings in multiple regulatory inspections, including FDA audits, EU GMP inspections, and assessments by the Chinese National Medical Products Administration (NMPA) and provincial regulatory agencies, while securing drug manufacturing licenses.

Ph.D. in Biophysics, University of Chinese Academy of Sciences;

Previous Research Associate (Postdoc), University of Wisconsin-Madison;

Experienced with iPSC/ESC culture and glia / neural differentiation. Dr. Wang has completed high-content and high-throughput screening of human glial cells and neurons derived from iPSC from Rett Syndrome patients at UWM. He leads the Hopstem R&D team to develop innovative iPSC cell products.

Ph.D. and postdoctoral fellow in Chemistry-Biomaterials, Technical University of Berlin;

More than 10 years of experience in stem cell nanomaterials and cytotoxicity study;

Responsible for clinical product development in Hopstem.

Ph.D. in neuroscience, School of medicine, Zhejiang University;

More than 10 years of training in Neuroscience, Cell Biology, and CRISPR gene editing;

Responsible for QC method development and technical support in Hopstem.

Master’s Degree of Nanjing University of Chinese Medicine;

25 years of experience in pharmaceutical registration, including First-in-Class new drugs, cell therapy products, and experience for China/US IND application;

Worked for Simcere Pharmaceutical, Nanjing King-Friend and MITRO Biotech;

Responsible for domestic/overseas registration in Hopstem.